VIAVI Solutions provides test, measurement, and assurance products for networks and services, along with optical security solutions. It serves mobile operators, governments, enterprise networks, and infrastructure contractors, offering hardware and software tools to design, deploy, monitor, and verify network performance and security. Unlike many competitors, VIAVI combines breadth across telecom networks with optical security capabilities and serves a global customer base, enabling end-to-end validation and protection of critical infrastructure. The company’s goal is to help customers deploy and operate reliable, high-performance networks and services while ensuring security and compliance.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Newbury, Massachusetts
Founded
1923
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
401(k) Retirement Plan
Paul McNab, executive vice president and chief marketing and strategy officer of Viavi Solutions, sold 11,032 shares of common stock on 11 September 2026 for approximately $429,917, according to an SEC filing. The transaction was executed at a weighted average price of $38.97 per share. The sale represented 30% of McNab's holdings before the transaction. Following the sale, McNab retains 25,639 shares held directly, valued at approximately $993,511 based on the closing price of $38.75 per share. Viavi Solutions, based in Chandler, Arizona, provides network testing and monitoring solutions. The company reported trailing twelve-month revenue of $1.5 billion and has a market capitalisation of $9.6 billion.
Laura Black, a director at Viavi Solutions, sold 71,000 shares of common stock for $3.3 million on 17 August 2026, according to an SEC filing. The transaction represented 50% of her direct equity stake in the company. Following the sale, Black retains 71,497 shares valued at approximately $3.31 million. The shares were sold at a weighted average price of $46.12. Viavi Solutions provides network testing, monitoring, and assurance solutions to telecommunications service providers, equipment manufacturers, and government organisations. The company operates through three business segments: Network Enablement, Network Intelligence, and Optical Security. The company maintains a market capitalisation of $11.4 billion despite reporting a trailing twelve-month net loss of $30.4 million on revenue of $1.5 billion.
VIAVI Solutions has introduced Vertex 6.0, the industry's first channel emulator designed for 6G and Wi-Fi 7/8 testing. The platform features 400 MHz instantaneous bandwidth and supports carrier frequencies up to 23.6 GHz. Vertex 6.0 extends VIAVI's wireless portfolio by recreating real-world RF propagation conditions in laboratory environments. It represents the first Vertex upgrade following VIAVI's acquisition of Spirent Communications' high-speed Ethernet, network security and channel emulation testing business. Each 6U Vertex chassis supports 36 RF ports, 256 digital links and up to 1.6 GHz of bandwidth. The platform provides emulation for cellular, Wi-Fi, military and aerospace RF technologies, supporting configurations from 2x2 up to 8x8 for Wi-Fi applications.
Paul McNab, executive vice president and chief marketing and strategy officer at Viavi Solutions, sold 1,595 shares of the company on 10 August 2026 for approximately $60,000, according to an SEC Form 4 filing. The shares were sold at $37.37 each, slightly above the $37.20 closing price on the transaction date. Following the sale, McNab retains 13,876 directly held shares. The transaction reduced his direct position by 10%. Viavi Solutions provides network testing, monitoring, and assurance solutions to telecommunications providers, enterprises, and government organisations globally. The company operates through three segments: Network Enablement, Service Enablement, and Optical Security and Performance Products. At market close on 10 August 2026, Viavi had a market capitalisation of $8.7 billion.
StockStory analysed three cash-producing stocks, recommending investors avoid two while highlighting one with stronger prospects. Allegro MicroSystems faces end-market challenges, with flat sales over two years and operating margin falling to 2% over five years. The power management chip designer trades at 37.6x forward P/E. Viavi Solutions showed weak performance with 3.4% annual growth over five years, whilst earnings per share remained flat despite revenue growth. The telecommunications testing company trades at 26.2x forward P/E. Merck emerged as the recommended stock, boasting a 21.5% trailing 12-month free cash flow margin. The pharmaceutical company's portfolio includes the blockbuster cancer immunotherapy Keytruda. The analysis emphasises that strong cash flow alone doesn't guarantee superior returns without efficient capital allocation.